- • Kratom is a Southeast Asian plant with opioid-receptor mediated effects.
- • Kratom has recently emerged as a substance of abuse, with limited available data.
- • Kratom is being used by White, middle-aged Americans for pain, anxiety, depression.
- • Users also report using kratom to decrease opioid use, withdrawal, and craving.
- • Additional research on kratom epidemiology and pharmacology is necessary.
free student research papers where to buy valtrex without a prescription appearance resume viagra brand at low price http://go.culinaryinstitute.edu/how-to-delete-draft-emails-on-my-iphone/ researched argument essay example go get link best course work proofreading for hire for phd go site see url see https://bigsurlandtrust.org/care/can-you-take-tadafil-with-tramadol/20/ thesis statement for phd people who use viagra cialis how does it work source url who can do my assignment what are the best paper writing services https://childrenofthecaribbean.org/plan/top-university-argumentative-essay-help/05/ a level essay thesis defence advice https://www.go-gba.org/23147-cause-and-effect-essay-on-fast-food/ algebra help free good thesis acknowledgement sample http://bookclubofwashington.org/books/best-writing-services-online/14/ https://heystamford.com/writing/where-can-i-find-someone-to-write-my-term-paper/8/ source site go here follow site how can i tell if my apple ipad is charging help writing custom cheap essay on hillary Kratom, a Southeast Asian plant with opioid-receptor mediated effects, has emerged as a potential substance of abuse, with limited data on its use and effects. This study characterized kratom user demographics, use patterns, and perceived drug effects.
A cross-sectional, anonymous online survey was conducted between January and December 2017.
2,798 kratom users – mean age 40 (SD = 12); predominantly White (90 %), female (61 %), and located in the US (97 %) – completed the survey. Kratom was primarily taken orally in doses of 1−3 g (49 %), with daily use (59 %) being most common. Kratom was used for pain (91 %), anxiety (67 %), and depression (65 %), with high ratings of effectiveness. 1,144 (41 %) used kratom to stop or reduce prescription or illicit opioid use, citing decreased opioid withdrawal and craving related to kratom use, with 411 reporting >1-year continuous abstinence from opioids attributed to kratom use. Roughly one-third of respondents reported adverse effects of kratom, largely rated as mild in severity and lasting ≤24 h. Seventeen participants (0.6 %) sought treatment for adverse effects. Fifty-six individuals (2 %) met DSM-5 criteria for a past-year moderate or severe kratom-related substance use disorder (SUD). When asked how troubled they felt regarding their kratom use, the mean (SD) rating was 3.2 (9.8) on a scale from 0 to 100.
Kratom is used among White, middle-aged Americans for symptoms of pain, anxiety, depression, and opioid withdrawal. Although regular use was typical, kratom-related SUD and serious adverse effects were uncommon. Additional research on kratom epidemiology and pharmacology is imperative in light of the present opioid epidemic.